July 2, 2026 · Form 4 insider transaction
McKechnie Duncan sold 1,541 shares of Vertex Pharmaceuticals Incorporated at $519.00 per share, a transaction worth $799.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.